Choose the right Slovenia guide
Slovenia CTIS Part II Document Checklist
Use this page to identify the standard and conditional Part II documents, their language, CTIS category, and submission-time signature status.
Read the CTIS Part II Document Checklist guide
Slovenia Patient Information and Consent Requirements
Start here when preparing the main Slovenian Patient Information Sheet and Informed Consent Form for adults able to consent.
Read the Patient Information and Consent Requirements guide
Slovenia Patient-Facing Document QC Checklist
Use this final review before uploading Slovenian participant materials, consent forms, recruitment content, diaries, questionnaires, and use-case variations.
Read the Patient-Facing Document QC Checklist guide
Slovenia Healthy Volunteer Consent Requirements
Use this variation when the trial recruits healthy volunteers and the information must explain non-therapeutic participation, payment, burden, and reproductive risk clearly.
Read the Healthy Volunteer Consent Requirements guide
Slovenia Minor Consent and Assent Requirements
Use this guide for parent or guardian consent, age-appropriate information, assent, Slovenia's 15-year threshold, dissent, and re-consent at adulthood.
Read the Minor Consent and Assent Requirements guide
Slovenia Limited-Capacity and Legal Representative Consent Requirements
Use this guide when an adult cannot provide legally valid consent and a legal representative must act while the participant remains involved as far as possible.
Read the Limited-Capacity and Legal Representative Consent Requirements guide
Slovenia Emergency Enrollment Consent Requirements
Use this guide only for a protocol designed to rely on the narrow emergency pathway in Article 35 of the Clinical Trials Regulation.
Read the Emergency Enrollment Consent Requirements guide
Slovenia Impartial Witness Consent Requirements
Use this guide when a participant or legal representative can consent but cannot write, making an impartial witness necessary for the consent record.
Read the Impartial Witness Consent Requirements guide
Slovenia Pregnancy Follow-Up Requirements
Use this guide for pregnancy-risk language, pregnant participants, pregnant partners, follow-up data, medical-record access, and separate consent decisions.
Read the Pregnancy Follow-Up Requirements guide
Slovenia Secondary Use Consent Requirements
Use this guide when optional future research will use identifiable or pseudonymised data, stored biological samples, or material beyond the main trial purpose.
Main Slovenia differences to plan for
Slovenian is mandatory for key documents
The national implementing regulation allows the application dossier in Slovenian or English, but makes three exceptions. The cover letter must be in Slovenian. A Slovenian protocol synopsis with the nationally specified short description is mandatory, and current EU language guidance calls for both English and Slovenian synopsis versions in a multinational application. Documents intended for participants must also be in Slovenian. This includes the Patient Information Sheet, Informed Consent Form, recruitment materials, participant cards, instructions, questionnaires completed by participants, and population-specific consent documents. The Slovenia Part II document checklist maps these language rules to the CTIS upload categories.
National ethics review is centralised
KME RS is the competent ethics committee for the Clinical Trials Regulation in Slovenia and prepares the Part II assessment. JAZMP performs validation, the scientific assessment, national coordination, and notification of the decision. A separate pre-submission ethics opinion is not a substitute for the CTIS assessment.
Slovenian participant information has national content expectations
KME RS expects clear, short, respectful, and lay-friendly information. Its published guidance asks for procedures, duration, benefits, risks, confidentiality, data access and retention, results availability, alternatives, withdrawal, insurance, and a named investigator contact. The consent form is signed when consent is obtained, not by future participants at CTIS submission. KME RS also publishes a short model consent form, but the model does not replace a trial-specific information and consent package. The main Slovenia patient information and consent guide explains the content and signature process.
Insurance must cover sponsor and investigator liability
Before the trial starts in Slovenia, insurance or another guarantee must cover both the sponsor's liability and the investigator's liability for damage suffered because of trial participation. The proof belongs in the Part II insurance category and should be aligned with the trial, Slovenian sites, participants, and planned conduct period.
Slovenia applies a 15-year consent-capacity presumption in healthcare
Under the Patients' Rights Act, a child younger than 15 is presumed unable to consent to healthcare unless the doctor considers the child sufficiently mature. A child aged 15 or older is presumed able unless the doctor finds otherwise. For a clinical trial, the Clinical Trials Regulation still requires consent from the legally designated representative for every participant who remains a minor. KME RS guidance also requires agreement from invited minors aged 15 or older in addition to parent or representative consent. The Slovenia minor consent and assent guide explains how the rules work together.
Trial consent and data-protection legal basis are different questions
Slovenia's Information Commissioner states that informed consent to participate in a clinical trial must not be treated automatically as consent under the General Data Protection Regulation. The controller must identify and document the correct legal basis for each processing purpose. Optional future research or sample use needs a separate, intelligible choice when consent is used. The Slovenia secondary-use guide covers that separation.
Other language versions
This package is the English version. A reciprocal link should be added here when the Slovenian-language hub and guides are published.
Prepare the full Slovenia package in minutes
Official sources and resources
- JAZMP, Clinical trial application submission under the Clinical Trials Regulation through CTIS, accessed 31 August 2026.
- Commission of the Republic of Slovenia for Medical Ethics, official clinical-trial and ethics page, updated 21 April 2026.
- Slovenia, Regulation implementing the EU Clinical Trials Regulation, Official Gazette RS No 132/2022.
- European Commission, Questions and Answers on Regulation (EU) No 536/2014, version published March 2026.
- European Commission, EudraLex Volume 10 clinical-trial guidance and Part II templates, accessed 31 August 2026.
- Regulation (EU) No 536/2014 on clinical trials, current consolidated access.
Last reviewed: 31 August 2026